Dimebon
The antihistamine Dimebon is a drug being studied in the United States and Russia as a potential treatment for Alzheimer's disease and Huntington's disease.1
In Russia, Dimebon became on obsolete drug of choice for allergies, but gained attention in 2000, when animal studies showed the possibility that it could treat Alzheimer's disease.2
In human clinical trials, Dimebon is showing to improve symptoms in neurodegenerative diseases in comparison to a placebo. In regards to Alzheimer's disease, Dimebon shows to help with cognitive function in mild to moderate cases. However, more research is vital for a better understanding of the drug's role in treating such diseases.3
Fast Facts
- Country of Origin: Russia
- Approved in Russia: 1983
- Manufacturer: Medivation Inc.
- Drug Type: Antihistamine
- Molecular Mass: 319.443 g/mol
Potential Treatment
- Neurodegenerative Disease
- Alzheimer's Disease
- Huntington's Disease
Disclaimer
The content on this page is not a substitute for professional medical advice. Please contact your physician for information on Dimebon.
Categories
